vs
Side-by-side financial comparison of Aeluma, Inc. (ALMU) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
Aeluma, Inc. is the larger business by last-quarter revenue ($1.3M vs $1.2M, roughly 1.1× Lucid Diagnostics Inc.). Aeluma, Inc. runs the higher net margin — -145.7% vs -858.5%, a 712.9% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -21.1%).
Aeluma, Inc. is a U.S.-headquartered technology firm focused on the design, development, and production of high-performance optoelectronic components and semiconductor products. Its core offerings include photonic sensors and laser diodes, serving the LiDAR, 5G/6G communication, industrial sensing, and automotive markets across North America and the Asia-Pacific region.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
ALMU vs LUCD — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $1.2M |
| Net Profit | $-1.9M | $-10.4M |
| Gross Margin | 27.8% | — |
| Operating Margin | -163.6% | -971.0% |
| Net Margin | -145.7% | -858.5% |
| Revenue YoY | -21.1% | 3.3% |
| Net Profit YoY | 36.0% | 16.0% |
| EPS (diluted) | $-0.11 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.4M | $1.2M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $828.0K | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $976.0K | ||
| Q1 24 | — | $1.0M |
| Q4 25 | $-1.9M | — | ||
| Q3 25 | $-1.5M | $-10.4M | ||
| Q2 25 | — | $-4.4M | ||
| Q1 25 | — | $-26.9M | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | — | $-12.4M | ||
| Q2 24 | — | $-11.0M | ||
| Q1 24 | — | $-10.6M |
| Q4 25 | 27.8% | — | ||
| Q3 25 | 49.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -163.6% | — | ||
| Q3 25 | -116.1% | -971.0% | ||
| Q2 25 | — | -978.8% | ||
| Q1 25 | — | -1508.1% | ||
| Q4 24 | — | -1033.8% | ||
| Q3 24 | — | -997.8% | ||
| Q2 24 | — | -1146.7% | ||
| Q1 24 | — | -1078.1% |
| Q4 25 | -145.7% | — | ||
| Q3 25 | -107.8% | -858.5% | ||
| Q2 25 | — | -381.7% | ||
| Q1 25 | — | -3249.8% | ||
| Q4 24 | — | -964.2% | ||
| Q3 24 | — | -1055.5% | ||
| Q2 24 | — | -1127.6% | ||
| Q1 24 | — | -1060.1% |
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.09 | $-0.10 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $38.6M | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $40.8M | $25.8M |
| Total Assets | $42.6M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.6M | — | ||
| Q3 25 | $25.9M | $47.3M | ||
| Q2 25 | — | $31.1M | ||
| Q1 25 | — | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $24.9M | ||
| Q1 24 | — | $24.8M |
| Q4 25 | $40.8M | — | ||
| Q3 25 | $40.9M | $25.8M | ||
| Q2 25 | — | $7.9M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $16.0M | ||
| Q1 24 | — | $11.9M |
| Q4 25 | $42.6M | — | ||
| Q3 25 | $42.7M | $53.2M | ||
| Q2 25 | — | $38.7M | ||
| Q1 25 | — | $32.8M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $34.1M | ||
| Q1 24 | — | $32.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-251.0K | $-10.9M |
| Free Cash FlowOCF − Capex | $-282.0K | — |
| FCF MarginFCF / Revenue | -22.2% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-251.0K | — | ||
| Q3 25 | $-815.0K | $-10.9M | ||
| Q2 25 | — | $-10.5M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $-9.9M | ||
| Q3 24 | — | $-10.2M | ||
| Q2 24 | — | $-11.5M | ||
| Q1 24 | — | $-12.6M |
| Q4 25 | $-282.0K | — | ||
| Q3 25 | $-1.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -22.2% | — | ||
| Q3 25 | -74.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 15.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
